The US Food and Drug Administration approved Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adu...
Intas is Cadila Pharmaceuticals's #1 competitor. Intas's headquarters is in Ahmedabad, Gujarat, and was founded in 1976. Like Cadila Pharmaceuticals, Intas also works within the Health Care Equipment & Services sector. Intas generates 92% of Cadila Pharmaceuticals's revenue.